| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Virus-like particles |
| Clinical data | |
| Routes of administration | Intramuscular |
| Part ofa series on the |
| COVID-19 pandemic |
|---|
|
Medical response |
|
LYB001 is aCOVID-19 vaccine candidate developed by Yantai Patronus Biotech Co., Ltd.[1][2][3][4]
It was found to be safe and well tolerated.[5]
This article about COVID-19 vaccines is astub. You can help Wikipedia byexpanding it. |
This article aboutvaccines orvaccination is astub. You can help Wikipedia byexpanding it. |